These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31 related articles for article (PubMed ID: 11938421)
1. Treatment of patients with chronic hepatitis C with normal liver enzymes. Akbar HO Saudi Med J; 2002 Mar; 23(3):301-4. PubMed ID: 11938421 [TBL] [Abstract][Full Text] [Related]
2. High initial dose combination regimen with interferon-alpha and ribavirin in chronic hepatitis C. Kotzev I; Ivanova I; Atanassova M; Atanassova A; Glinkova V; Gancheva D; Shalev I; Manevska B; Krasnaliev I; Tomcheva S Hepatogastroenterology; 2003; 50(50):463-6. PubMed ID: 12749248 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity]. Karpińska E; Wawrzynowicz-Syczewska M; Jurczyk K; Morańska I; Urbanowicz W; Boroń-Kaczmarska A Wiad Lek; 2005; 58(11-12):616-21. PubMed ID: 16594470 [TBL] [Abstract][Full Text] [Related]
4. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C. Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response. Halfon P; Khiri H; Tran A; Pénaranda G; Courcambeck J; Joly H; Ouzan D Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1067-71. PubMed ID: 14501613 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C. Honda T; Katano Y; Urano F; Murayama M; Hayashi K; Ishigami M; Nakano I; Yoshioka K; Toyoda H; Kumada T; Goto H J Gastroenterol Hepatol; 2007 Jul; 22(7):989-95. PubMed ID: 17608843 [TBL] [Abstract][Full Text] [Related]
8. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response. Chu CM; Sheen IS; Liaw YF Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075 [TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
10. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490 [TBL] [Abstract][Full Text] [Related]
11. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857 [TBL] [Abstract][Full Text] [Related]
12. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy. Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of chronic hepatitis C treatment in hemophilic patients. Husa P; Roznovsky L; Smejkal P; Husova L; Penka M; Dite P Hepatogastroenterology; 2005; 52(65):1541-4. PubMed ID: 16201114 [TBL] [Abstract][Full Text] [Related]
14. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770 [TBL] [Abstract][Full Text] [Related]
15. The effect of interferon alpha plus ribavirin on health-related quality of life in chronic C hepatitis. The Romanian experience. Pojoga C; Dumitraşcu DL; Pascu O; Grigorescu M J Gastrointestin Liver Dis; 2006 Mar; 15(1):31-5. PubMed ID: 16680230 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of chronic hepatitis C with interferon alpha and ribavirin. Results in "real life"]. Pariente A; Djilloul A; Cadranel JF; Gastroenterol Clin Biol; 2003 Jun; 27(6-7):590-5. PubMed ID: 12910222 [TBL] [Abstract][Full Text] [Related]
17. Effect of induction therapy on Hepatitis C. Akbar HO Saudi Med J; 2002 Jul; 23(7):773-6. PubMed ID: 12174222 [TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C treatment without liver biopsy]. Siboni A Ugeskr Laeger; 2002 Mar; 164(11):1522-3; discussion 1523-4. PubMed ID: 11924484 [No Abstract] [Full Text] [Related]
19. [Chronic hepatitis and cholangitis. The liver at risk]. MMW Fortschr Med; 1999 Jun; 141(25):20-1. PubMed ID: 10897899 [No Abstract] [Full Text] [Related]
20. [The efficacy of pharmacotherapy in patients with chronic liver pathology and the function of the antioxidant defense enzymes]. Loginov AS; Matiushin BN; Iakimchuk GN Ter Arkh; 1995; 67(2):3-6. PubMed ID: 7725254 [No Abstract] [Full Text] [Related] [Next] [New Search]